Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Jayakrishna Ambati
University of Kentucky, Department: Ophthalmology
Should you be removed from our database? Contact us at [email protected]. Read more below.
Inflammasome Therapeutics, LLC
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
NA
Non-canonical NLRP3 Inflammasome Activation in Geographic Atrophy
Recently we have discovered that the over-activation of the NLRP3 inflammasome pathway plays an essential role in the development of geographic atrophy (GA), an untreatable cause of blindness. However, the mechanisms that govern inflammasome activation in GA are poorly understood. Our proposed research will help gain a deeper understanding of these inflammasome-regulatory pathways to identify novel, critical molecules that can be targeted for treating GA and other inflammasomopathies.
Filed on November 04, 2015.
Tell us what you know about Jayakrishna Ambati's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Jayakrishna Ambati”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Jayakrishna Ambati | University of Kentucky | Conflict of Interest | Allergan | $60,000 - $79,999 |
| Jayakrishna Ambati | University of Kentucky | Conflict of Interest | iVeena Pharma, LLC | Value cannot be readily determined |
| Jayakrishna Ambati | University of Kentucky | Conflict of Interest | Inflammasome Therapeutics, LLC | Value cannot be readily determined |
| Jayakrishna Ambati | University of Virginia | Conflict of Interest | iVeena Pharmaceuticals, LLC | Value cannot be readily determined |
| Jayakrishna Ambati | University of Kentucky | Conflict of Interest | Allergan | $60,000 - $79,999 |
| Jayakrishna Ambati | University of Kentucky | Conflict of Interest | iVeena Pharma, LLC | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.